CARBOCAINE Side Effects

6848408-9 | Cardiac Arrest, Convulsion, Tachycardia
on Jul 15, 2010 Female patient from FRANCE , 56 years of age, was diagnosed with local anaesthesia and was treated with Carbocaine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), convulsion, tachycardia. Carbocaine dosage: 2 %, Single Administration. During the same period patient was treated with NAROPIN (7.5 Mg/ml, Single Administration) (View Naropin Review and Naropin Label ).

6715014-6 | Cardiac Failure, Dyspnoea, Multi-organ Failure
Patient was taking Carbocaine (View Usage). Patient had the following side effects: cardiac failure, dyspnoea, multi-organ failure on May 03, 2010 from FRANCE Additional patient health information: Female patient , 78 years of age, . Carbocaine dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), CRESTOR (View Crestor Review and Crestor Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), AMLOR (View Amlor Review and Amlor Label ), INSULIN (View Insulin Review and Insulin Label ), SEASONAL FLU VACCINE (View Seasonal Flu Vaccine Review and Seasonal Flu Vaccine Label ).

6456694-2 | Aphasia, Hypersensitivity, Musculoskeletal Disorder, Post Procedural Complication, Syncope
Adverse event was reported on Nov 10, 2009 by a Male patient taking Carbocaine (View Usage) (Dosage: Frequency Once, Injection) . Location: UNITED STATES , 40 years of age, weighting 180.0 lb, After Carbocaine was administered, patient had the following side effects: aphasia (What is aphasia?), hypersensitivity, musculoskeletal disorder, post procedural complication, syncope.

6265659-5 | Dyspnoea, Feeling Hot, Hypotension, Nausea
on Jul 09, 2009 Female patient from UNITED STATES , child 11 years of age, weighting 100.0 lb, was treated with Carbocaine (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, feeling hot, hypotension, nausea (What is nausea?). Carbocaine dosage: .


5833624-5 | Dyskinesia, Loss Of Consciousness, Muscle Rigidity
on Jul 21, 2008 Female patient from FRANCE , weighting 143.3 lb, was diagnosed with local anaesthesia, ischaemic cardiomyopathy and was treated with Carbocaine (View Usage). Patient had the following side effects: dyskinesia, loss of consciousness, muscle rigidity. Carbocaine dosage: . During the same period patient was treated with NAROPEINE (View Naropeine Review and Naropeine Label ), ULTIVA (0.05 G/kg/minute) (View Ultiva Review and Ultiva Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5749967-X | Dysphagia, Dysphonia, Overdose, Tongue Paralysis
Patient was taking Carbocaine (View Usage). After Carbocaine was administered, patient had the following side effects: dysphagia, dysphonia, overdose, tongue paralysis on May 26, 2008 from FRANCE Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with anaesthesia and. Carbocaine dosage: . Patient was hospitalized.

5749715-3 | Dysphagia, Dysphonia, Overdose, Tongue Paralysis
Adverse event was reported on May 26, 2008 by a Female patient taking Carbocaine (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: FRANCE , 51 years of age, Patient experienced the following unwanted or unexpected effects: dysphagia, dysphonia, overdose, tongue paralysis. Patient was hospitalized.

5725264-3 | Dysphagia, Dysphonia, Tongue Paralysis
on Apr 22, 2008 Female patient from FRANCE , 51 years of age, was diagnosed with anaesthesia and was treated with Carbocaine (View Usage). Patient had the following side effects: dysphagia, dysphonia, tongue paralysis. Carbocaine dosage: . Patient was hospitalized.

5723903-4 | Dysphagia, Dysphonia, Tongue Paralysis
on Apr 22, 2008 Male patient from FRANCE , weighting 165.3 lb, was diagnosed with anaesthesia and was treated with Carbocaine (View Usage). After Carbocaine was administered, patient had the following side effects: dysphagia, dysphonia, tongue paralysis. Carbocaine dosage: . Patient was hospitalized.

5713025-0 | Dysphagia, Dysphonia, Paraesthesia Oral
Patient was taking Carbocaine (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, dysphonia, paraesthesia oral on Apr 18, 2008 from FRANCE Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with anaesthesia and. Carbocaine dosage: . Patient was hospitalized.

5713024-9 | Dysphagia, Dysphonia, Paraesthesia Oral
Adverse event was reported on Apr 18, 2008 by a Female patient taking Carbocaine (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: FRANCE , 51 years of age, Patient had the following side effects: dysphagia, dysphonia, paraesthesia oral. Patient was hospitalized.

5275665-5 | Hepatitis, Overdose
on Mar 19, 2007 Female patient from FRANCE , 60 years of age, weighting 132.3 lb, was diagnosed with anaesthesia and was treated with Carbocaine (View Usage). After Carbocaine was administered, patient had the following side effects: hepatitis (What is hepatitis?), overdose. Carbocaine dosage: . During the same period patient was treated with CEFACIDAL (View Cefacidal Review and Cefacidal Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ). Patient was hospitalized.

5155301-9 | Anaphylactic Shock
on Sep 18, 2006 Female patient from FRANCE , weighting 123.5 lb, was diagnosed with postoperative analgesia and was treated with Carbocaine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Carbocaine dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), NIMBEX (View Nimbex Review and Nimbex Label ), DESFLURANE (View Desflurane Review and Desflurane Label ), IMOVANE (View Imovane Review and Imovane Label ), ATARAX (View Atarax Review and Atarax Label ).

5119395-9 | Cardiac Disorder, Circulatory Collapse, Hypotension, Laryngeal Oedema, Overdose, Tachycardia
Patient was taking Carbocaine (View Usage). Patient had the following side effects: cardiac disorder, circulatory collapse, hypotension, laryngeal oedema, overdose, tachycardia on Sep 18, 2006 from FRANCE Additional patient health information: Female patient , 44 years of age, was diagnosed with local anaesthesia and. Carbocaine dosage: . During the same period patient was treated with AUGMENTIN (Amoxicillin 2 G / Clavulanic Acid 200 Mg) (View Augmentin Review and Augmentin Label ).

5109204-6 | Circulatory Collapse, Laryngeal Oedema, Overdose
Adverse event was reported on Sep 18, 2006 by a Female patient taking Carbocaine (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: FRANCE , 44 years of age, After Carbocaine was administered, patient had the following side effects: circulatory collapse, laryngeal oedema, overdose. During the same period patient was treated with AUGMENTIN (Amoxicillin 2 G / Clavulanic Acid 200 Mg) (View Augmentin Review and Augmentin Label ).

4879561-4 | Corneal Opacity, Visual Acuity Reduced
on Jan 05, 2006 Female patient from FRANCE , 68 years of age, weighting 176.4 lb, was diagnosed with local anaesthesia and was treated with Carbocaine (View Usage). Patient experienced the following unwanted or unexpected effects: corneal opacity, visual acuity reduced. Carbocaine dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ATARAX (View Atarax Review and Atarax Label ), AQSIA (View Aqsia Review and Aqsia Label ), CILOXAN (View Ciloxan Review and Ciloxan Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ), ACULAR (View Acular Review and Acular Label ), NEOSYNEPHRINE (View Neosynephrine Review and Neosynephrine Label ), DIAMOX (View Diamox Review and Diamox Label ).

4864492-6 | Neuromuscular Block Prolonged
on Nov 07, 2005 Male patient from FRANCE , weighting 202.8 lb, was diagnosed with nerve block and was treated with Carbocaine (View Usage). Patient had the following side effects: neuromuscular block prolonged. Carbocaine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

4688020-3 | Convulsion, Shock
Patient was taking Carbocaine (View Usage). After Carbocaine was administered, patient had the following side effects: convulsion, shock on May 25, 2005 from Additional patient health information: Male patient , 79 years of age, was diagnosed with epidural anaesthesia and. Carbocaine dosage: .

4680689-2 | Burning Sensation, Hypoaesthesia
Adverse event was reported on May 19, 2005 by a Female patient taking Carbocaine (View Usage) (Dosage: ) was diagnosed with local anaesthesia, back pain (What is back pain?) and. Location: , 70 years of age, Patient experienced the following unwanted or unexpected effects: burning sensation, hypoaesthesia.

4678001-8 | Loss Of Consciousness, Shock
on May 25, 2005 Male patient from , 79 years of age, was diagnosed with local anaesthesia and was treated with Carbocaine (View Usage). Patient had the following side effects: loss of consciousness, shock. Carbocaine dosage: .

4577562-7 | Amnesia, Anaesthetic Complication, Convulsion, Eye Disorder, Overdose, Sinus Bradycardia
on Jan 28, 2005 Female patient from , 76 years of age, weighting 143.3 lb, was diagnosed with anaesthesia and was treated with Carbocaine (View Usage). After Carbocaine was administered, patient had the following side effects: amnesia, anaesthetic complication, convulsion, eye disorder, overdose, sinus bradycardia. Carbocaine dosage: 800 Mg Once Rnb. During the same period patient was treated with LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), TANAKAN (View Tanakan Review and Tanakan Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), VASTEN (View Vasten Review and Vasten Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).